BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 25899764)

  • 1. Optimal vancomycin doses for methicillin-resistant Staphylococcus aureus infection in urological renal dysfunction patients.
    Shigemura K; Osawa K; Yamamichi F; Tanaka K; Tokimatsu I; Arakawa S; Fujisawa M
    Int Urol Nephrol; 2015 Jun; 47(6):887-91. PubMed ID: 25899764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation for optimal dosing of vancomycin in patients with different physical types.
    Hashimoto M; Iketani O; Ichinose N; Enoki Y; Taguchi K; Uno S; Uwamino Y; Hasegawa N; Matsumoto K
    J Infect Chemother; 2019 Sep; 25(9):735-737. PubMed ID: 31126752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical usefulness of the new Japanese glomerular filtration rate equation for initial and individualized dosage adjustment concentrations of vancomycin].
    Kuroda N; Ueshima S; Sato T; Kobiki E; Kawasaki Y; Matsunaga H; Nakura H; Sendo T
    Yakugaku Zasshi; 2012; 132(1):125-33. PubMed ID: 22214587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of pharmacist intervention in Vancomycin treatment for patients with bacteremia due to Methicillin-resistant Staphylococcus aureus.
    Komoto A; Maiguma T; Teshima D; Sugiyama T; Haruki Y
    PLoS One; 2018; 13(9):e0203453. PubMed ID: 30188918
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vancomycin loading dose is associated with increased early clinical response without attainment of initial target trough concentration at a steady state in patients with methicillin-resistant Staphylococcus aureus infections.
    Ueda T; Takesue Y; Nakajima K; Ichiki K; Ishikawa K; Takai Y; Yamada K; Wada Y; Tsuchida T; Otani N; Takahashi Y; Ishihara M; Shibata S; Ikeuchi H; Uchino M; Kimura T
    J Clin Pharm Ther; 2020 Aug; 45(4):682-690. PubMed ID: 32301537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of various estimates of renal function on prediction of vancomycin concentration by the population mean and Bayesian methods.
    Tsuji Y; Hiraki Y; Mizoguchi A; Sadoh S; Sonemoto E; Kamimura H; Karube Y
    J Clin Pharm Ther; 2009 Aug; 34(4):465-72. PubMed ID: 19583680
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duration of Systemic Inflammatory Response Syndrome Influences Serum Vancomycin Concentration in Patients With Sepsis.
    Chuma M; Makishima M; Imai T; Tochikura N; Sakaue T; Kikuchi N; Kinoshita K; Kaburaki M; Yoshida Y
    Clin Ther; 2016 Dec; 38(12):2598-2609. PubMed ID: 27836495
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of inhaled vancomycin hydrochloride on elimination of methicillin-resistant Staphylococcus aureus].
    Shirai M; Ide K; Sato M; Murakami M; Tanaka Y; Sato A; Chida K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1995 Nov; 33(11):1233-9. PubMed ID: 8583715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Initial dose of vancomycin based on body weight and creatinine clearance to minimize inadequate trough levels in Japanese adults.
    Maki N; Ohkuchi A; Tashiro Y; Kim MR; Le M; Sakamoto T; Matsubara S; Hakamata Y
    Eur J Clin Microbiol Infect Dis; 2012 Oct; 31(10):2537-43. PubMed ID: 22391760
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of factors associated with the achievement of an optimal teicoplanin trough concentration
.
    Takechi K; Yanagawa H; Zamami Y; Ishizawa K; Tanaka A; Araki H
    Int J Clin Pharmacol Ther; 2017 Aug; 55(8):672-677. PubMed ID: 28655381
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Delivery of novel vancomycin nanoplexes for combating methicillin resistant Staphylococcus aureus (MRSA) infections.
    Hassan D; Omolo CA; Gannimani R; Waddad AY; Mocktar C; Rambharose S; Agrawal N; Govender T
    Int J Pharm; 2019 Mar; 558():143-156. PubMed ID: 30641177
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comprehensive evaluation of fibrin glue as a local drug-delivery system-efficacy and safety of sustained release of vancomycin by fibrin glue against local methicillin-resistant Staphylococcus aureus infection.
    Ozaki S; Saito A; Nakaminami H; Ono M; Noguchi N; Motomura N
    J Artif Organs; 2014 Mar; 17(1):42-9. PubMed ID: 24292855
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of safe and effective dose of vancomycin in MRSA-infected patients using serum cystatin C concentrations.
    Chen YC; Feng JF; Li B; Zhang L; Yang YW
    Int J Clin Pharmacol Ther; 2013 Mar; 51(3):161-9. PubMed ID: 23195915
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sustained-release vancomycin sheet may help to prevent prosthetic graft methicillin-resistant Staphylococcus aureus infection.
    Hirose K; Marui A; Arai Y; Nomura T; Inoue S; Kaneda K; Kamitani T; Fujita M; Mitsuyama M; Tabata Y; Komeda M
    J Vasc Surg; 2006 Aug; 44(2):377-82. PubMed ID: 16890872
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Desired vancomycin trough serum concentration for treating invasive methicillin-resistant Staphylococcal infections.
    Frymoyer A; Guglielmo BJ; Hersh AL
    Pediatr Infect Dis J; 2013 Oct; 32(10):1077-9. PubMed ID: 23652479
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Risk factors for vancomycin nephrotoxicity and time course of renal function during vancomycin treatment.
    Hirai T; Hanada K; Kanno A; Akashi M; Itoh T
    Eur J Clin Pharmacol; 2019 Jun; 75(6):859-866. PubMed ID: 30770940
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A stewardship program's retrospective evaluation of vancomycin AUC24/MIC and time to microbiological clearance in patients with methicillin-resistant Staphylococcus aureus bacteremia and osteomyelitis.
    Gawronski KM; Goff DA; Brown J; Khadem TM; Bauer KA
    Clin Ther; 2013 Jun; 35(6):772-9. PubMed ID: 23795575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Achievement of Therapeutic Vancomycin Trough Serum Concentrations with Empiric Dosing in Neonatal Intensive Care Unit Patients.
    Ringenberg T; Robinson C; Meyers R; Degnan L; Shah P; Siu A; Sturgill M
    Pediatr Infect Dis J; 2015 Jul; 34(7):742-7. PubMed ID: 25629890
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linezolid versus vancomycin for nosocomial pneumonia due to methicillin-resistant Staphylococcus aureus in the elderly: A retrospective cohort analysis: Effectiveness of linezolid in the elderly.
    Takada H; Hifumi T; Nishimoto N; Kanemura T; Yoshioka H; Okada I; Kiriu N; Inoue J; Koido Y; Kato H
    Am J Emerg Med; 2017 Feb; 35(2):245-248. PubMed ID: 27832976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Correlation of pharmacokinetic parameters with serum vancomycin concentration in elderly patients with malignancies].
    Sadoh S; Tsuji Y; Tsukamoto K
    Yakugaku Zasshi; 2010 Jan; 130(1):69-73. PubMed ID: 20046068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.